G6PD functions as a metabolic checkpoint to regulate granzyme B expression in tumor-specific cytotoxic T lymphocytes

Background Granzyme B is a key effector of cytotoxic T lymphocytes (CTLs), and its expression level positively correlates with the response of patients with mesothelioma to immune checkpoint inhibitor immunotherapy. Whether metabolic pathways regulate Gzmb expression in CTLs is incompletely understo...

Full description

Bibliographic Details
Main Authors: Colby, A.H (Author), Colson, Y.L (Author), Ding, H.-F (Author), Grinstaff, M.W (Author), Klement, J.D (Author), Liu, K. (Author), Lu, C. (Author), Oberlies, N.H (Author), Pearce, C.J (Author), Shi, H. (Author), Yang, D. (Author)
Format: Article
Language:English
Published: BMJ Publishing Group 2022
Subjects:
Online Access:View Fulltext in Publisher